Executive Management
Dr. Bradley S. Galer, MD
President, Pain Group
Dr. Galer is a world renowned authority in the field of pain medicine and analgesic drug development. In his current role at Nuvo, Dr. Galer oversees the the operations of the Pain Group, including its drug development activities, business development and licensing opportunities and liaising with partners. Prior to joining Nuvo, Dr. Galer was employed at Endo Pharmaceuticals as Senior Medical Officer and Group Vice President, Scientific Affairs, where he was responsible for the departments of Clinical and Biostatistics, Medical Affairs, Pharmacovigilance, Medical Liaison and Medical Information. He and his team successfully filed NDAs for Opana ER/IR and Depodur and was instrumental in the clinical and regulatory success of Lidoderm. In 1998 to 2000, Dr. Galer was on staff at the Department of Pain Medicine at Beth Israel Medical Center in New York. From 1991 to 2000, Dr. Galer was a consultant to numerous pharmaceutical companies developing analgesic drugs, including Lidoderm, Flector, Neurontin, and Lyrica. From 1992 to 1998, Dr. Galer was Assistant Professor at the University of Washington School of Medicine, Seattle, on the faculty of what is now the Department of Anesthesiology & Pain Medicine Dr. Galer has published over 200 articles and book chapters regarding pain management. He co-authored the book “Clinical Guide to Neuropathic Pain” and the soon-to-be published book for patients titled “Defeating Chronic Pain.” He is the Founding Editor-in-Chief of the journal Current Pain and Headache Reports and was the Associate Editor of The Clinical Journal of Pain. Dr. Galer received his medical doctorate and a neurology residency at Albert Einstein in New York and two Pain Fellowships, at Memorial Sloane-Kettering in New York and University of California San Francisco. He also attended the Executive Pharmaceutical Business Programs at both Wharton and Harvard Business School.
